Educational Resources

Viant shares expertise on material advances in orthopedics including titanium-coated PEEK, Nitinol, and bioabsorbables.

A large supplier of orthopedic devices obtained an established arthroscopic product line as part of an acquisition.

A large surgical technology company was facing a competitive threat and needed to rapidly re-engineer one of its market-leading devices to lower the cost of use.

A fast-growing, midsize company in the spine market sought a supplier that could support the development of a new universal case and tray system for all its current and future reusable spinal surgery instruments.

A large surgical device company was planning to commercialize a first-of-its-kind articulating vessel sealer to strengthen its portfolio in the advanced energy device segment of the laparoscopic surgery market.

A leading global animal health company came to Viant for help with the manufacturing transfer of IV sets & accessories.

A global surgical technology company needed an external partner to help develop and manufacture tubing for an advanced energy device with measurably better performance than other leading devices.

Our CEO Brian King speaks to how we are forging a new future as Viant (July 9, 2018).

With health providers increasingly demanding single-use devices, the team successfully created disposable bone-cutting tools for its orthopedic device customers.

Company Appoints former Medtronic and Integer Executives to Leadership Team Following Integer AS&O Acquisition

Company Unveils New Name After Acquiring Integer’s Advanced Surgical and Orthopedics Business

Successful OEMs recognize their top service providers as development partners instead of transactional suppliers.

John Greisch Joins Board as Viant Continues Global Services Expansion

Disposition Provides Integer Financial Flexibility to Strengthen Medical Device Outsourcing Leadership Position. Strategic Acquisition to Bolster Viant's Portfolio of Medical Device Manufacturing Capabilities.

If you’re considering a manufacturing transfer, you may be losing sleep over all the things that could go wrong: cost overruns, schedule slips, or quality issues, to name a few. Missteps anywhere in the process can make the difference between meeting or missing your timeline and budget.

Sept. 26-27, 2018 Galway, Ireland

Company Appoints Longtime Medical Device Executive to Advance Growth Strategy

A midsize, market-leading blood management company was having major quality issues with the molding supplier for critical components of its flagship product, resulting in supply chain interruptions and a high rate of customer complaints.

A mid-sized medical device company was ready to ramp up production of a complex, single-patient-use endoscopic device, but its initial supplier was unable to meet the volume requirements.

A leading, multinational medical technology company was seeking a strategic partner to develop and manufacture a key component of its next-generation, catheter-based stent delivery system: a tapered tip flexible enough to pass through the tortuous vessel.

A leading, multinational medical technology company needed to transfer manufacturing of a medical device to free up cleanroom manufacturing space for a new product. The customer was facing an aggressive 12-month time frame for the transfer to avoid interrupting product supply.